Efavirenz (Sustiva, Stocrin)

Published January 25, 2001; Updated May 2013
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-03
Selected Reference
13. Cohen CJ, Molina JM, Cahn P, et al; ECHO Study Group; THRIVE Study Group. Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials. J Acquir Immune Defic Syndr. 2012 May 1;60(1):33-42.